115 related articles for article (PubMed ID: 10021297)
1. Absence of human papillomavirus E6-E7 transforming genes from HPV 16 and 18 in malignant ovarian carcinoma.
Chen TR; Chan PJ; Seraj IM; King A
Gynecol Oncol; 1999 Feb; 72(2):180-2. PubMed ID: 10021297
[TBL] [Abstract][Full Text] [Related]
2. Quantitation of human papillomavirus 16 E6 and E7 DNA and RNA in residual material from ThinPrep Papanicolaou tests using real-time polymerase chain reaction analysis.
Wang-Johanning F; Lu DW; Wang Y; Johnson MR; Johanning GL
Cancer; 2002 Apr; 94(8):2199-210. PubMed ID: 12001118
[TBL] [Abstract][Full Text] [Related]
3. Detection of human papillomavirus DNA and genotyping in patients with epithelial ovarian carcinoma.
Atalay F; Taskiran C; Taner MZ; Pak I; Or M; Tuncer S
J Obstet Gynaecol Res; 2007 Dec; 33(6):823-8. PubMed ID: 18001449
[TBL] [Abstract][Full Text] [Related]
4. Human papillomavirus DNA is present in a subset of unselected breast cancers.
Liu Y; Klimberg VS; Andrews NR; Hicks CR; Peng H; Chiriva-Internati M; Henry-Tillman R; Hermonat PL
J Hum Virol; 2001; 4(6):329-34. PubMed ID: 12082399
[TBL] [Abstract][Full Text] [Related]
5. A multifaceted study of human papillomavirus and prostate carcinoma.
Strickler HD; Burk R; Shah K; Viscidi R; Jackson A; Pizza G; Bertoni F; Schiller JT; Manns A; Metcalf R; Qu W; Goedert JJ
Cancer; 1998 Mar; 82(6):1118-25. PubMed ID: 9506358
[TBL] [Abstract][Full Text] [Related]
6. [Inverted papilloma and its association with human papillomavirus (HPV). A study with polymerase chain reaction (PCR)].
Arndt O; Nottelmann K; Brock J; Neumann OG
HNO; 1994 Nov; 42(11):670-6. PubMed ID: 7843998
[TBL] [Abstract][Full Text] [Related]
7. [Causal association between human papilloma virus infection and head and neck and esophageal squamous cell carcinoma].
Szentirmay Z; Szántó I; Bálint I; Pólus K; Remenár E; Tamás L; Szentkúti G; Melegh Z; Nagy P; Kásler M
Magy Onkol; 2002; 46(1):35-41. PubMed ID: 12050680
[TBL] [Abstract][Full Text] [Related]
8. [Detection of human papillomavirus in laryngeal carcinoma with digoxigenin labelled probe prepared by polymerase chain reaction].
Zhao S; Ye Q; Lu S
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 1999 Mar; 13(1):13-6. PubMed ID: 12759943
[TBL] [Abstract][Full Text] [Related]
9. Role of human papillomavirus in the development of epithelial ovarian neoplasms in Italian women.
Giordano G; D'Adda T; Gnetti L; Froio E; Merisio C; Melpignano M
J Obstet Gynaecol Res; 2008 Apr; 34(2):210-7. PubMed ID: 18412784
[TBL] [Abstract][Full Text] [Related]
10. Human papillomavirus (HPV) transcripts in malignant inverted papilloma are from integrated HPV DNA.
McKay SP; Grégoire L; Lonardo F; Reidy P; Mathog RH; Lancaster WD
Laryngoscope; 2005 Aug; 115(8):1428-31. PubMed ID: 16094117
[TBL] [Abstract][Full Text] [Related]
11. Induction of the p53-target gene GADD45 in HPV-positive cancer cells.
Butz K; Whitaker N; Denk C; Ullmann A; Geisen C; Hoppe-Seyler F
Oncogene; 1999 Apr; 18(14):2381-6. PubMed ID: 10327059
[TBL] [Abstract][Full Text] [Related]
12. Prevention of carcinoma of cervix with human papillomavirus vaccine.
Gavarasana S; Kalasapudi RS; Rao TD; Thirumala S
Indian J Cancer; 2000; 37(2-3):57-66. PubMed ID: 11876611
[TBL] [Abstract][Full Text] [Related]
13. Analysis of ovarian tumors for the presence of human papillomavirus DNA.
Quirk JT; Kupinski JM; DiCioccio RA
J Obstet Gynaecol Res; 2006 Apr; 32(2):202-5. PubMed ID: 16594925
[TBL] [Abstract][Full Text] [Related]
14. Failure to detect human papillomavirus DNA in malignant epithelial neoplasms of conjunctiva by polymerase chain reaction.
Eng HL; Lin TM; Chen SY; Wu SM; Chen WJ
Am J Clin Pathol; 2002 Mar; 117(3):429-36. PubMed ID: 11888082
[TBL] [Abstract][Full Text] [Related]
15. Prognostic significance of lymph node variables and human papillomavirus DNA in invasive vulvar carcinoma.
Pinto AP; Schlecht NF; Pintos J; Kaiano J; Franco EL; Crum CP; Villa LL
Gynecol Oncol; 2004 Mar; 92(3):856-65. PubMed ID: 14984953
[TBL] [Abstract][Full Text] [Related]
16. Selective silencing of viral gene expression in HPV-positive human cervical carcinoma cells treated with siRNA, a primer of RNA interference.
Jiang M; Milner J
Oncogene; 2002 Sep; 21(39):6041-8. PubMed ID: 12203116
[TBL] [Abstract][Full Text] [Related]
17. E6/E7 expression of human papillomavirus types in cutaneous squamous cell dysplasia and carcinoma in immunosuppressed organ transplant recipients.
Dang C; Koehler A; Forschner T; Sehr P; Michael K; Pawlita M; Stockfleth E; Nindl I
Br J Dermatol; 2006 Jul; 155(1):129-36. PubMed ID: 16792764
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of human papillomavirus-consensus primers for HPV detection by the polymerase chain reaction.
Harnish DG; Belland LM; Scheid EE; Rohan TE
Mol Cell Probes; 1999 Feb; 13(1):9-21. PubMed ID: 10024428
[TBL] [Abstract][Full Text] [Related]
19. No metastatic cervical adenocarcinomas in a series of p16INK4a-positive mucinous or endometrioid advanced ovarian carcinomas: an analysis of the AGO Ovarian Cancer Study Group.
Wentzensen N; du Bois A; Kommoss S; Pfisterer J; von Knebel Doeberitz M; Schmidt D; Kommoss F
Int J Gynecol Pathol; 2008 Jan; 27(1):18-23. PubMed ID: 18156969
[TBL] [Abstract][Full Text] [Related]
20. "Low-risk" and "high-risk" HPV-infection and K-ras gene point mutations in human cervical cancer: a study of 31 cases.
Stenzel A; Semczuk A; Rózyńskal K; Jakowicki J; Wojcierowski J
Pathol Res Pract; 2001; 197(9):597-603. PubMed ID: 11569923
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
